PARONYCHIA side effect
What is PARONYCHIA ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
PARONYCHIA and Recently Reported Side Effects
PARONYCHIA and 15 most Active Side Effect polls
PARONYCHIA and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with PARONYCHIA
CAPECITABINE CETUXIMAB ENBREL ERBITUX ERLOTINIB IRESSA LAPATINIB TARCEVA TYKERB TYVERB VECTIBIXTarceva Side Effects Report #5536566-8
Physician from FRANCE reported TARCEVA problem on Nov 19, 2007. Male patient, 70 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: paronychia, . TARCEVA dosage: 150 MG (150 MG, QD); ORAL. During the same period patient was treated with ASPIRIN, CORVASAL, CELIPROLOL, MIPRAL, LASIX, VOLTAREN, LYRICA, POTASSIUM CHLORIDE. Patient recovered.
Erlotinib Side Effects Report #5691939-8
ERLOTINIB problem was reported by a Health Professional from JAPAN on Feb 11, 2008. Male patient, 82 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: paronychia, . ERLOTINIB dosage: 150 MG,QD),ORAL. Patient recovered.
Cetuximab Side Effects Report #5618302-X
Health Professional from UNITED STATES reported CETUXIMAB problem on Feb 05, 2008. Female patient, weighting 243.6 lb, was diagnosed with breast cancer metastatic and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: paronychia, staphylococcal infection, . CETUXIMAB dosage: 250MG/M2 WEEKLY IV. During the same period patient was treated with CARBOPLATIN, TRAZODONE HYDROCHLORIDE, VESICARE, WELLBUTRIN, LEVAQUIN, CLINDAMYCIN, MAGNESIUM, SULFACETIMIDE. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5629426-5
CETUXIMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 15, 2008. Female patient, weighting 243.6 lb, was diagnosed with breast cancer metastatic and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: paronychia, staphylococcal infection, . CETUXIMAB dosage: 250MG/M2 WEEKLY. During the same period patient was treated with CARBOPLATIN, TRAZODONE HYDROCHLORIDE, VESICARE, WELLBUTRIN, LEVAQUIN, CLINDAMYCIN, MAGNESIUM. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5536566-8
Physician from FRANCE reported TARCEVA problem on Nov 19, 2007. Male patient, 70 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: paronychia, . TARCEVA dosage: 150 MG (150 MG, QD); ORAL. During the same period patient was treated with ASPIRIN, CORVASAL, CELIPROLOL, MIPRAL, LASIX, VOLTAREN, LYRICA, POTASSIUM CHLORIDE. Patient recovered.
Tykerb Side Effects Report #5506537-6
TYKERB problem was reported by a Physician from FRANCE on Oct 26, 2007. Female patient, 56 years of age, weighting 132.3 lb, was diagnosed with breast cancer metastatic and was treated with TYKERB. After drug was administered, patient experienced the following problems/side effects: paronychia, . TYKERB dosage: 1250MG PER DAY. During the same period patient was treated with CAPECITABINE. Patient recovered.
Tykerb Side Effects Report #5530636-6
Physician from FRANCE reported TYKERB problem on Nov 21, 2007. Female patient, 56 years of age, weighting 132.3 lb, was treated with TYKERB. After drug was administered, patient experienced the following problems/side effects: paronychia, . TYKERB dosage: 1250MG PER DAY. During the same period patient was treated with CAPECITABINE. Patient recovered.
Vectibix Side Effects Report #5495197-9
VECTIBIX problem was reported by a Physician from UNITED STATES on July 16, 2007. Female patient, weighting 191.1 lb, was diagnosed with colorectal cancer and was treated with VECTIBIX. After drug was administered, patient experienced the following problems/side effects: paronychia, . VECTIBIX dosage: unknown. Patient recovered.
Erlotinib Side Effects Report #5765517-6
Physician from JAPAN reported ERLOTINIB problem on May 19, 2008. Female patient, 75 years of age, was diagnosed with lung adenocarcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: paronychia, rash, stomatitis, . ERLOTINIB dosage: (150 MG, QD), ORAL. During the same period patient was treated with NORVASC. Patient recovered.
Erlotinib Side Effects Report #5732115-X
ERLOTINIB problem was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2008. Female patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: paronychia, . ERLOTINIB dosage: (150 MG, QD(, ORAL. Patient recovered.
Lapatinib Side Effects Report #5749488-4
Physician from FRANCE reported LAPATINIB problem on May 13, 2008. Female patient, 57 years of age, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: paronychia, . LAPATINIB dosage: 1250MG PER DAY. During the same period patient was treated with XELODA. Patient was hospitalized. Patient recovered.
Iressa Side Effects Report #5690894-4
IRESSA problem was reported by a Physician from JAPAN on Mar 28, 2008. Female patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with IRESSA. After drug was administered, patient experienced the following problems/side effects: paronychia, rash, . IRESSA dosage: unknown. During the same period patient was treated with HALFDIGOXIN, SELBEX, MUCOSOLVAN, MAGMITT, ARTIST, URSO, RINDERON. Patient recovered.
Iressa Side Effects Report #5705769-1
Physician from JAPAN reported IRESSA problem on Apr 08, 2008. Female patient, 60 years of age, weighting 94.80 lb, was diagnosed with lung neoplasm malignant, tachyarrhythmia, gastritis, hypertension, hepatitis c, rash and was treated with IRESSA. After drug was administered, patient experienced the following problems/side effects: paronychia, rash, . IRESSA dosage: unknown. During the same period patient was treated with HALFDIGOXIN, SELBEX, ARTIST, URSO, HIBON, PYDOXAL, MUCOSOLVAN. Patient recovered.
Capecitabine Side Effects Report #5255382-8
CAPECITABINE problem was reported by a Physician from UNITED STATES on Feb 27, 2007. Male patient, 58 years of age, weighting 198.4 lb, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: paronychia, performance status decreased, . CAPECITABINE dosage: unknown. During the same period patient was treated with CETUXIMAB, OXALIPLATIN, LASIX, SPIROLACTONE, PROPRANOLOL, LACTULOSE, MG OXIDE. Patient was hospitalized. Patient recovered.
Capecitabine Side Effects Report #5266323-1
Physician from UNITED STATES reported CAPECITABINE problem on Mar 06, 2007. Male patient, 58 years of age, weighting 198.4 lb, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: paronychia, performance status decreased, . CAPECITABINE dosage: unknown. During the same period patient was treated with CETUXIMAB, OXALIPLATIN, LASIX, SPIROLACTONE, PROPRANOLOL, LACTULOSE, MG OXIDE. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5603409-3
TARCEVA problem was reported by a Physician from AUSTRIA on Jan 04, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: acne, paronychia, . TARCEVA dosage: (150 MG), ORAL. During the same period patient was treated with VINORELBINE TARTRATE, PEMETREXED. Patient recovered.
Cetuximab Side Effects Report #5605282-6
Physician from UNITED STATES reported CETUXIMAB problem on Jan 23, 2008. Female patient, weighting 243.6 lb, was diagnosed with breast cancer metastatic and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: localised infection, paronychia, staphylococcal infection, . CETUXIMAB dosage: 250MG/M2 IV WEEKLY. During the same period patient was treated with CARBOPLATIN, TRAZODONE HYDROCHLORIDE, VESICARE, WELLBUTRIN, LEVAQUIN, CLINDAMYCIN, MAGNESIUM, SULFACETIMIDE TOPICAL. Patient was hospitalized. Patient recovered.
Vectibix Side Effects Report #5495199-2
VECTIBIX problem was reported by a Physician from UNITED STATES on July 19, 2007. Female patient, weighting 244.3 lb, was diagnosed with colorectal cancer and was treated with VECTIBIX. After drug was administered, patient experienced the following problems/side effects: blood magnesium decreased, paronychia, . VECTIBIX dosage: unknown. During the same period patient was treated with MAGNESIUM SULPHATE. Patient recovered.
Tarceva Side Effects Report #5466212-3
Physician from FRANCE reported TARCEVA problem on Sept 11, 2007. Male patient was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: no therapeutic response, paronychia, . TARCEVA dosage: 150 MG (QD), ORAL. Patient recovered.
Erlotinib Side Effects Report #5782206-2
ERLOTINIB problem was reported by a Physician from JAPAN on June 03, 2008. Male patient, 66 years of age, was diagnosed with lung adenocarcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: impetigo, paronychia, skin haemorrhage, . ERLOTINIB dosage: (150 MG, QD), ORAL. During the same period patient was treated with FAMOTIDINE, MOBIC, MELOXICAM. Patient recovered.
Tyverb Side Effects Report #5742708-1
Physician from FRANCE reported TYVERB problem on May 14, 2008. Female patient, 53 years of age, was treated with TYVERB. After drug was administered, patient experienced the following problems/side effects: palmar-plantar erythrodysaesthesia syndrome, paronychia, ulcer, . TYVERB dosage: 1250MG PER DAY. During the same period patient was treated with XELODA. Patient recovered.
Erlotinib Side Effects Report #5702459-6
ERLOTINIB problem was reported by a Health Professional from JAPAN on Mar 25, 2008. Male patient, 82 years of age, was diagnosed with lung adenocarcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: folliculitis, paronychia, . ERLOTINIB dosage: 150 MG, QD, ORAL. During the same period patient was treated with IRESSA, EVIPROSTAT, SENNOSIDE, NAIXAN, RIZE, GASMOTIN, MAGNESIUM OXIDE, RABEPRAZOLE. Patient recovered.
Iressa Side Effects Report #5264321-5
Health Professional from UNITED STATES reported IRESSA problem on Jan 31, 2005. Female patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with IRESSA. After drug was administered, patient experienced the following problems/side effects: conjunctivitis, paronychia, . IRESSA dosage: unknown. Patient recovered.
Iressa Side Effects Report #5264359-8
IRESSA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 04, 2005. Female patient, 69 years of age, weighting 114.0 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with IRESSA. After drug was administered, patient experienced the following problems/side effects: cystitis, paronychia, . IRESSA dosage: unknown. During the same period patient was treated with CELEBREX, ACTONEL. Patient recovered.
Enbrel Side Effects Report #5636358-5
Health Professional from FRANCE reported ENBREL problem on Feb 11, 2008. Female patient, weighting 125.7 lb, was diagnosed with psoriatic arthropathy, psoriasis, insomnia, mineral supplementation, hypothyroidism, pain, hypercholesterolaemia and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: dermatitis psoriasiform, leukocytoclastic vasculitis, paronychia, . ENBREL dosage: unknown. During the same period patient was treated with MOPRAL, STILNOX, LEVOTHYROX, NEXEN, ELISOR. Patient recovered.
Tykerb Side Effects Report #5564987-6
TYKERB problem was reported by a Physician from GERMANY on Dec 11, 2007. Female patient, 40 years of age, weighting 152.1 lb, was treated with TYKERB. After drug was administered, patient experienced the following problems/side effects: blister, nail bed bleeding, paronychia, . TYKERB dosage: 1250MG PER DAY. During the same period patient was treated with XELODA. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5767417-4
Health Professional from TAIWAN, PROVINCE OF CHINA reported ERBITUX problem on May 29, 2008. Male patient, 74 years of age, weighting 207.2 lb, was diagnosed with rectosigmoid cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, dermatitis acneiform, paronychia, renal failure acute, sepsis, toxic epidermal necrolysis, . ERBITUX dosage: unknown. During the same period patient was treated with IRINOTECAN, LEUCOVORIN CALCIUM, FLUOROURACIL, DOXYCYCLINE, LORAZEPAM, FENTANYL, FAMOTIDINE, DOXAZOSIN MESYLATE. Patient was hospitalized. Patient died on 08/13/2006.
Erbitux Side Effects Report #5773727-7
ERBITUX problem was reported by a Health Professional from TAIWAN, PROVINCE OF CHINA on June 10, 2008. Male patient, 74 years of age, weighting 207.2 lb, was diagnosed with rectosigmoid cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, dermatitis acneiform, paronychia, renal failure acute, sepsis, toxic epidermal necrolysis, . ERBITUX dosage: unknown. During the same period patient was treated with IRINOTECAN, LEUCOVORIN CALCIUM, FLUOROURACIL, DOXYCYCLINE, LORAZEPAM, FENTANYL, FAMOTIDINE, DOXAZOSIN MESYLATE. Patient was hospitalized. Patient died on 08/13/2006.
Erbitux Side Effects Report #5776603-9
Health Professional from TAIWAN, PROVINCE OF CHINA reported ERBITUX problem on June 12, 2008. Male patient, 74 years of age, weighting 207.2 lb, was diagnosed with rectosigmoid cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, dermatitis acneiform, paronychia, renal failure acute, sepsis, toxic epidermal necrolysis, . ERBITUX dosage: unknown. During the same period patient was treated with IRINOTECAN, LEUCOVORIN CALCIUM, FLUOROURACIL, DOXYCYCLINE, LORAZEPAM, FENTANYL, FAMOTIDINE, DOXAZOSIN MESYLATE. Patient was hospitalized. Patient died on 08/13/2006.
Erlotinib Side Effects Report #5792665-7
ERLOTINIB problem was reported by a Physician from JAPAN on June 09, 2008. Female patient, 73 years of age, was diagnosed with lung adenocarcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: dermatitis acneiform, hepatic function abnormal, paronychia, seborrhoeic dermatitis, vomiting, . ERLOTINIB dosage: (150 MG,QD), ORAL. During the same period patient was treated with FAMOTIDINE, URSO, VITAMEDIN, CINAL, LENDORM, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Tyverb Side Effects Report #5714625-4
Physician from SWITZERLAND reported TYVERB problem on Apr 18, 2008. Female patient, 40 years of age, weighting 176.4 lb, was diagnosed with breast cancer metastatic and was treated with TYVERB. After drug was administered, patient experienced the following problems/side effects: dry skin, palmar-plantar erythrodysaesthesia syndrome, paronychia, skin exfoliation, . TYVERB dosage: 1250MG PER DAY. During the same period patient was treated with XELODA. Patient recovered.